Acid-phosphatase reaction in acute lymphoblastic leukaemia

Area of Science:

• Hematology
• Oncology
• Clinical Pathology

Background:

• Acute lymphoblastic leukaemia (A.L.L.) is a heterogeneous disease.
• Accurate subtyping of A.L.L. is crucial for effective treatment strategies.
• Surface-membrane markers are established for A.L.L. classification.

Purpose of the Study:

• To evaluate the diagnostic utility of the acid-phosphatase reaction in A.L.L.
• To correlate acid-phosphatase positivity with specific A.L.L. subtypes.
• To assess the potential of this cytochemical test in guiding A.L.L. therapy.

Main Methods:

• A double-blind assessment of the acid-phosphatase reaction was performed.
• 148 cases of A.L.L. were analyzed, classified by surface-membrane markers.
• Data were collected from the Medical Research Council (M.R.C.) United Kingdom A.L.L. trials.

Main Results:

• A positive acid-phosphatase reaction was observed in 90% of T-A.L.L. cases.
• Only 2% of common-A.L.L. and 10% of null-A.L.L. cases showed a positive reaction.
• The reaction demonstrated a significant difference across A.L.L. subtypes.

Conclusions:

• The acid-phosphatase reaction effectively distinguishes T-A.L.L. from other subtypes.
• This cytochemical marker identifies a more aggressive form of A.L.L.
• Acid-phosphatase testing may assist in selecting appropriate therapeutic approaches for A.L.L.